Search Results - "Irina G. Mudrikova"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    INFLUENCE OF TYPE 2 SODIUM-GLUCOSE CO-TRANSPORTER INHIBITORS (DAPAGLIFLOZIN) ON THE INDICATORS OF TOTAL MORTALITY IN PATIENTS WITH TYPE 2 DIABETES (CARDIA-MOS STUDY, MOSCOW) by Mikhail B. Antsiferov, Nikolay A. Demidov, Maria A. Balberova, Olga V. Lobanova, Irina G. Mudrikova, Dinara G. Gusenbekova

    Published in Sakharnyĭ diabet (01-12-2022)
    “…BACKGROUND: Widespread clinical use of drugs with cardioprotective/nephroprotective properties – particularly sodium-glucose cotransporter type 2 inhibitors…”
    Get full text
    Journal Article
  2. 2

    Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow) by Antsiferov, M. B., Demidov, N. A., Balberova, M. A., Lobanova, O. V., Mudrikova, I. G., Gusenbekova, D. G.

    Published in Sakharnyĭ diabet (01-12-2022)
    “…BACKGROUND: The widespread use in clinical practice of drugs with cardio- and nephroprotective properties, in particular, sodium-glucose cotransporter type 2…”
    Get full text
    Journal Article